AVIVA welcomes you to innovation.
Our latest endeavor is a revolutionary approach to analyze blood and bodily fluids. The RedSift Cell Processor recovers cells of interest in a highly efficient manner while eliminating red blood cells and platelets from your sample. Isolated cells are ready for rapid analysis by flow cytometry, quantitative PCR, next generation sequencing (NGS), FISH, laser capture, and virtually any assay using whole cells as sample input. Learn more about innovative cell enrichment methods when you visit our RedSift Cell Processor section.
Prepare your preclinical drug candidates for future FDA guidelines using the Comprehensive in Vitro Proarrhythmia Assay (CIPA).